The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This is a single-blind, Investigator Initiated study to evaluate the safety and efficacy of
Vyvanse™ and provide pilot data in two areas: (1) on the use of Near-Infrared Spectroscopy to
detect medication effects in children with ADHD; and (2) on the influence of Vyvanse ™ on
reading fluency and comprehension, over a period of approximately 6-8 weeks. Subjects will be
between the ages of 6 and 12 at the beginning of the study.